March 6, 2025 11:41 AM EST
Manufacturing

Cor­den­Phar­ma’s €100M in­vest­ment top-up; Cy­ti­va to lay off 85 staffers

Anna Brown

News Reporter

Wel­come to End­points News’ man­u­fac­tur­ing briefs, where we bring you es­sen­tial news on new builds, col­lab­o­ra­tions, re­calls and more.

Cor­den­Phar­ma is

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

How blue­bird's buy­out of­fer went from $100M up­front to $29M

At $300M Kardi­gan start­up, for­mer MyoKar­dia team un­veils its first drug, and it comes from Io­n­is

Roche launch­es new re­search cen­ter with Har­vard in Boston area

Bay­er eyes cap­i­tal raise as it grap­ples with Mon­san­to cas­es

What the FDA, NIH hear­ings tell us about drug and health pol­i­cy un­der Trump

sponsored

The per­fect storm: Why every­thing is in place for 2025 to be the year of GxP AI

A service from the Financial Times